학술논문
INTRAVITREAL BEVACIZUMAB IS SUPERIOR TO LASER FOR DIABETIC MACULAR OEDEMA. TWO-YEAR RESULTS FROM THE BOLT STUDY
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
14426404